Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CETIRIZINE HYDROCHLORIDE ALLERGY | BionPharma | N-022429 OTC | 2009-07-23 | 1 products, RLD |
CETIRIZINE HYDROCHLORIDE HIVES RELIEF | BionPharma | N-022429 OTC | 2009-07-23 | 2 products, RLD |
CETIRIZINE HYDROCHLORIDE ALLERGY | BionPharma | N-022429 OTC | 2009-07-23 | 1 products, RLD, RS |
ZERVIATE | Harrow | N-208694 RX | 2017-05-30 | 1 products, RLD, RS |
CHILDREN'S ZYRTEC HIVES RELIEF | Johnson & Johnson | N-022155 OTC | 2007-11-16 | 1 products, RLD, RS |
CHILDREN'S ZYRTEC ALLERGY | Johnson & Johnson | N-022155 OTC | 2007-11-16 | 1 products, RLD, RS |
CHILDREN'S ZYRTEC ALLERGY | Johnson & Johnson | N-021621 OTC | 2007-11-16 | 2 products, RLD |
ZYRTEC ALLERGY | Johnson & Johnson | N-022578 OTC | 2010-09-03 | 1 products, RLD, RS |
ZYRTEC ALLERGY | Johnson & Johnson | N-019835 OTC | 2007-11-16 | 1 products, RLD, RS |
QUZYTTIR | JDP Therapeutics | N-211415 RX | 2019-10-04 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZYRTEC-D 12 HOUR | Johnson & Johnson | N-021150 OTC | 2007-11-09 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
12 hour allergy d | ANDA | 2020-09-03 |
24 hour allergy | New Drug Application | 2024-04-01 |
all day | ANDA | 2020-06-18 |
all day allergy | ANDA | 2025-04-07 |
all day allergy d | ANDA | 2025-02-12 |
all day allergy relief | ANDA | 2024-12-20 |
all day allergy relief d | ANDA | 2018-12-06 |
allergy | ANDA | 2024-06-03 |
allergy and congestion relief d | ANDA | 2023-05-30 |
allergy relief | ANDA | 2025-03-13 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Cetirizine Hydrochloride, Zerviate, Eyevance | |||
9254286 | 2032-07-09 | DP | |
8829005 | 2030-03-15 | U-1680 | |
9750684 | 2030-03-15 | DP | |
9993471 | 2030-03-15 | U-1680 | |
Cetirizine Hydrochloride, Quzyttir, Jdp | |||
8263581 | 2030-02-28 | U-2635 | |
8314083 | 2030-02-28 | U-2634 | |
8513259 | 2030-02-11 | U-2636 | |
9119771 | 2030-02-11 | U-2635 | |
9180090 | 2030-02-11 | U-2635 |
Code | Description |
---|---|
J1201 | Injection, cetirizine hydrochloride, 0.5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Disease | D004194 | EFO_0000408 | R69 | — | — | — | — | 2 | 2 |
Healthy volunteers/patients | — | — | — | — | — | — | — | 2 | 2 |
Drug common name | Cetirizine |
INN | cetirizine |
Description | Cetirizine is a member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively. It has a role as an anti-allergic agent, a H1-receptor antagonist, an environmental contaminant and a xenobiotic. It is a monocarboxylic acid, a member of piperazines, a member of monochlorobenzenes and an ether. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 |
PDB | — |
CAS-ID | 83881-51-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1000 |
ChEBI ID | 3561 |
PubChem CID | 2678 |
DrugBank | DB00341 |
UNII ID | YO7261ME24 (ChemIDplus, GSRS) |